US 11879003
Methods for increasing T-cell function
granted A61KA61K40/11A61K40/31
Quick answer
US patent 11879003 (Methods for increasing T-cell function) held by Kyverna Therapeutics, Inc. expires Mon Jan 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Kyverna Therapeutics, Inc.
- Grant date
- Tue Jan 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K40/11, A61K40/31, A61K40/4242, A61K40/4254